Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21449886 | 0.74 | ALDH1A1 (0.47) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL16607543 | 0.74 | ALDH1A1 (0.47) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL17532418 | 0.72 | ALDH1A1 (0.57) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL18544899 | 0.70 | ALDH1A1 (0.41) | ALDH1A1TP53TSHRKMT2ACYP3A4 | |
| SCHEMBL18516108 | 0.70 | ALDH1A1 (0.44) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL24303344 | 0.69 | ALDH1A1 (0.53) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL12308314 | 0.69 | NPSR1 (0.46) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL9796552 | 0.69 | ALDH1A1 (0.57) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL9550340 | 0.69 | ALDH1A1 (0.42) | ALDH1A1LMNATP53TSHRKMT2A | |
| SCHEMBL17532435 | 0.69 | ALDH1A1 (0.46) | ALDH1A1LMNATP53TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3853219-B1 | HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINE HYDRAZIDES | BAYER AG (DE) | 2023-07-12 | — | — | EP | disclosed |
| WO-2020058062-A1 | HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINE HYDRAZIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-03-26 | — | — | WO | disclosed |
| US-20100273924-A1 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION | SIKA TECHNOLOGY AG (CH) | 2010-10-28 | — | — | US | disclosed |
| EP-2225298-A1 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION | Sika Technology AG (CH) | 2010-09-08 | — | — | EP | disclosed |
| WO-2009080738-A1 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION | SIKA TECHNOLOGY AG (CH) | 2009-07-02 | — | — | WO | disclosed |
| EP-2072550-A1 | Hardening compounds with reduced gas emission | Sika Technology AG (CH) | 2009-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273924-A1 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION | CA4, CTH, CA6 | ALDH1A1 205/4885LMNA 2384/4885TP53 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.